These health-tech veterans want to avert the next Theranos disaster with ‘medical diligence’
August 11, 2019 | Uncategorized
Ruby Gadelrab and Jill Hagenkord are hoping to bridge the gap between technology and medicine, and help investors vet start-ups for potential red flags.
